Clearance of Cervical Human Papillomavirus Infection by Topical Application of Curcumin and Curcumin Containing Polyherbal Cream: A Phase II Randomized Controlled Study |
Basu, Partha
(Department of Gynecological Oncology, Chittaranjan National Cancer Institute)
Dutta, Sankhadeep (Department of Oncogene Regulation, Chittaranjan National Cancer Institute) Begum, Rakiba (Department of Gynecological Oncology, Chittaranjan National Cancer Institute) Mittal, Srabani (Department of Gynecological Oncology, Chittaranjan National Cancer Institute) Dutta, Paromita Das (Department of Dietetics and Nutrition, Chittaranjan National Cancer Institute) Bharti, Alok Chandra (Institute of Cytology and Preventive Oncology, NOIDA) Panda, Chinmay Kumar (Department of Oncogene Regulation, Chittaranjan National Cancer Institute) Biswas, Jaydip (Chittaranjan National Cancer Institute) Dey, Bindu (Department of Biotechnology, Ministry of Science and Technology, Government of India) Talwar, Gursaran Prashad (Talwar Research Foundation) Das, Bhudev Chandra (Dr. BR Ambedkar Center for Biomedical Research) |
1 | Grimm C, Polterauer S, Natter C, et al (2012). Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Obstet Gynecol, 120, 152-9. DOI |
2 | Beutner KR, Spruance SL, Hougham AJ, et al (1998). Treatment of genital warts with an immuneresponse modifier (imiquimod). J Am Acad Dermatol, 38, 230-9. DOI ScienceOn |
3 | Bharti AC, Shukla S, Mahata S, Hedau S, Das BC (2009). Antihuman papillomavirus therapeutics: facts and future. Ind J Med Res, 130, 296-310. |
4 | Divya CS, Pillai MR (2006). Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog, 45, 320-32. DOI ScienceOn |
5 | Dutta S, Begum R, Mazumder D, et al (2012). Prevalence of human papillomavirus in women without cervical cancer: a population-based study in Eastern India. Int J Gynecol Pathol, 31, 178-83. |
6 | Gupta N, Gupta SK (2011). Microbicides: a new hope for HIV prevention. Ind J Med Res, 134, 939-49. DOI |
7 | Khan MJ, Castle PE , Lorincz AT, et al (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. JNCI, 97, 1072-9. DOI ScienceOn |
8 | Sterling JC, Handfield-Jones S, Hudson P (2001). Guidelines for the management of cutaneous warts. Br J Dermatol, 144, 4-11 DOI ScienceOn |
9 | Kjaer SK, van den Brule AJ, Paull G, et al (2002). Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ, 325, 572-8. DOI ScienceOn |
10 | Molano M, van den Brule A, Plummer M, et al (2003). Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study. Am J Epidemiol, 158, 486-94. DOI ScienceOn |
11 | Talwar GP, Dar SA, Rai MK, et al (2008). A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens, Int J Antimicrob Agents, 32, 180-5. DOI ScienceOn |
12 | Talwar GP, Raghuvanshi P, Mishra R, et al (2000). Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens. Am J Rep Immunol, 43, 144-51. DOI ScienceOn |
13 | van Duin M, Snijders PJ, Schrijnemakers HF, et al (2002). Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer, 98, 590-5 DOI ScienceOn |
14 | Vermani K, Garg S (2002). Herbal medicines for sexually transmitted diseases and AIDS, J Ethnopharmacol, 80, 49-66. DOI ScienceOn |
15 | Maher DM, Bell MC, O'Donnell EA, et al (2011). Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Mol Carcinog, 50, 47-57. DOI ScienceOn |